DIN 02397137 — STRIBILD 150 MG; 200 MG; 300 MG; 150 MG
STRIBILD is a tablet of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Disoproxil Fumarate marketed by GILEAD SCIENCES CANADA INC. The full Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Disoproxil Fumarate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02397137
- Brand name
- STRIBILD
- Strength
- 150 MG; 200 MG; 300 MG; 150 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Antiretroviral agent - fixed-dose combination integrase inhibitor with a pharmacokinetic enhancer and two nucleos(t)ide reverse transcriptase inhibitors
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.